Correvio Pharma Corp. Pre-Tax Income
Correvio Pharma Corp. reported Pre-Tax Income of -$35.01 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2020-04-30
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|
| 2019-12-31 | -$35.01M 20-F · filed 2020-04-30 |
| 2018-12-31 | -$16.54M 20-F · filed 2020-04-30 |
| 2017-12-31 | -$29.45M 20-F · filed 2020-04-30 |
| 2016-12-31 | -$19.47M 20-F · filed 2018-04-30 |
| 2015-12-31 | -$24.47M 20-F · filed 2018-04-30 |
| 2014-12-31 | -$18.18M 40-F · filed 2016-03-29 |
| 2013-12-31 | $4.88M 40-F · filed 2015-03-27 |
| 2012-12-31 | -$18.32M 40-F/A · filed 2014-04-30 |